Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Alcoholic hepatitis

Alcoholic hepatitis

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Alcoholic hepatitis

8 trials tracked for Alcoholic hepatitis.

8Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 7 Other / NA 1
  1. Phase 2 Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis Completed
  2. Phase 2 A Safety and Efficacy Study of Mycophenolate Mofetil and Rilonacept in Patients With Alcoholic Hepatitis Completed
  3. Phase 2 A Research Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DUR-928 in Patients With Alcoholic Hepatitis Completed
  4. Phase 2 Safety and Efficacy of IMM 124-E for Patients With Severe Alcoholic Hepatitis Completed
  5. Phase 2 Use of F-652 in Patients With Alcoholic Hepatitis Completed
  6. Phase 2 Vitamin C Infusion for TReatment in Sepsis and Alcoholic Hepatitis Completed
Show 2 more trials
  1. Phase 2 IL-1 Signal Inhibition in Alcoholic Hepatitis Completed
  2. N/A Alcoholic Hepatitis Network Observational Study Completed

Showing the 8 most-cited and recently-updated of 8 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Mesenchymal stem cells alleviate liver injury and inflammation in preclinical alcoholic hepatitis models
Gastroenterology Meta-analysis
Mesenchymal stem cells alleviate liver injury and inflammation in preclinical alcoholic hepatitis models Stem cells show promise in treating liver damage from alcohol
This meta-analysis of transcriptomic signatures evaluates the effects of mesenchymal stem cells on alcoholic hepatitis in mice. The study fo…
New research in mice shows that stem cells may reduce liver inflammation and scarring caused by heavy alcohol use.
Sep 15, 2026
MELD and MELD-Na demonstrate higher specificity than Maddrey discriminant function for alcoholic hepatitis mortality
Gastroenterology Meta-analysis
MELD and MELD-Na demonstrate higher specificity than Maddrey discriminant function for alcoholic hepatitis mortality New data compares scoring tools for alcoholic hepatitis mortality
This systematic review and diagnostic meta-analysis compared MDF, MELD, and MELD-Na scores for predicting mortality in patients with alcohol…
Doctors use different scoring systems to predict survival in patients with alcoholic hepatitis, but new data shows no major difference betwe…
Jul 1, 2026